Literature DB >> 17846883

No association between the LRRK2 G2019S mutation and Alzheimer's disease in Italy.

Andrea Tedde1, Silvia Bagnoli, Elena Cellini, Benedetta Nacmias, Silvia Piacentini, Sandro Sorbi.   

Abstract

AIMS: Investigation of the leucine-rich repeat kinase 2 (LRRK2) gene in late-onset Alzheimer's disease (AD) patients to screen for the G2019S mutation, which is common in Parkinson's cases.
METHODS: High-resolution melting analysis (HRMA) was used to screen a large sample of patients. The target sequence was amplified by standard PCR in the presence of an intercalating fluorescent dye. Heterozygotes were easily identified because the heteroduplexes produced changed the shape of the melting curve.
RESULTS: In accordance to previous studies, we did not detect the G2019S mutation in any of the 769 Italian AD patients under study.
CONCLUSIONS: HMRA allowed us to rapidly characterize a large number of samples for the LRRK2 G2019S mutation, which results as absent in a large AD data set.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17846883     DOI: 10.1007/s10571-007-9207-4

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  18 in total

1.  High-resolution DNA melting analysis for simultaneous mutation scanning and genotyping in solution.

Authors:  Luming Zhou; Lesi Wang; Robert Palais; Robert Pryor; Carl T Wittwer
Journal:  Clin Chem       Date:  2005-10       Impact factor: 8.327

2.  LRRK2 G6055A mutation in Italian patients with familial or sporadic Parkinson's disease.

Authors:  D Civitelli; P Tarantino; G Nicoletti; I C Cirò Candiano; F Annesi; E V De Marco; S Carrideo; F E Rocca; F Condino; P Spadafora; P Pugliese; S D'Asero; M Morelli; S Paglionico; G Annesi; A Quattrone
Journal:  Clin Genet       Date:  2007-04       Impact factor: 4.438

3.  LRRK2 mutations are not common in Alzheimer's disease.

Authors:  Mathias Toft; Sigrid Botne Sando; Stacey Melquist; Owen A Ross; Linda R White; Jan O Aasly; Matthew J Farrer
Journal:  Mech Ageing Dev       Date:  2005-11       Impact factor: 5.432

4.  LRRK2 mutations and Parkinson's disease in Sardinia--A Mediterranean genetic isolate.

Authors:  Giovanni Cossu; Marina van Doeselaar; Marcello Deriu; Maurizio Melis; Andrea Molari; Alessio Di Fonzo; Ben A Oostra; Vincenzo Bonifati
Journal:  Parkinsonism Relat Disord       Date:  2006-10-24       Impact factor: 4.891

5.  Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

Authors:  A Goate; M C Chartier-Harlin; M Mullan; J Brown; F Crawford; L Fidani; L Giuffra; A Haynes; N Irving; L James
Journal:  Nature       Date:  1991-02-21       Impact factor: 49.962

6.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease.

Authors:  W J Strittmatter; A M Saunders; D Schmechel; M Pericak-Vance; J Enghild; G S Salvesen; A D Roses
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

7.  Comprehensive analysis of the LRRK2 gene in sixty families with Parkinson's disease.

Authors:  Alessio Di Fonzo; Cristina Tassorelli; Michele De Mari; Hsin F Chien; Joaquim Ferreira; Christan F Rohé; Giulio Riboldazzi; Angelo Antonini; Gianni Albani; Alessandro Mauro; Roberto Marconi; Giovanni Abbruzzese; Leonardo Lopiano; Emiliana Fincati; Marco Guidi; Paolo Marini; Fabrizio Stocchi; Marco Onofrj; Vincenzo Toni; Michele Tinazzi; Giovanni Fabbrini; Paolo Lamberti; Nicola Vanacore; Giuseppe Meco; Petra Leitner; Ryan J Uitti; Zbigniew K Wszolek; Thomas Gasser; Erik J Simons; Guido J Breedveld; Stefano Goldwurm; Gianni Pezzoli; Cristina Sampaio; Egberto Barbosa; Emilia Martignoni; Ben A Oostra; Vincenzo Bonifati
Journal:  Eur J Hum Genet       Date:  2006-03       Impact factor: 4.246

8.  LRRK2 G2019S mutation and Parkinson's disease: a clinical, neuropsychological and neuropsychiatric study in a large Italian sample.

Authors:  Stefano Goldwurm; Michela Zini; Alessio Di Fonzo; Danilo De Gaspari; Chiara Siri; Erik J Simons; Marina van Doeselaar; Silvana Tesei; Angelo Antonini; Margherita Canesi; Anna Zecchinelli; Claudio Mariani; Nicoletta Meucci; Giorgio Sacilotto; Roberto Cilia; Ioannis U Isaias; A Bonetti; Francesca Sironi; Sara Ricca; Ben A Oostra; Vincenzo Bonifati; Gianni Pezzoli
Journal:  Parkinsonism Relat Disord       Date:  2006-06-05       Impact factor: 4.891

9.  The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.

Authors:  S Goldwurm; A Di Fonzo; E J Simons; C F Rohé; M Zini; M Canesi; S Tesei; A Zecchinelli; A Antonini; C Mariani; N Meucci; G Sacilotto; F Sironi; G Salani; J Ferreira; H F Chien; E Fabrizio; N Vanacore; A Dalla Libera; F Stocchi; C Diroma; P Lamberti; C Sampaio; G Meco; E Barbosa; A M Bertoli-Avella; G J Breedveld; B A Oostra; G Pezzoli; V Bonifati
Journal:  J Med Genet       Date:  2005-11       Impact factor: 6.318

10.  Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease.

Authors:  R Sherrington; E I Rogaev; Y Liang; E A Rogaeva; G Levesque; M Ikeda; H Chi; C Lin; G Li; K Holman; T Tsuda; L Mar; J F Foncin; A C Bruni; M P Montesi; S Sorbi; I Rainero; L Pinessi; L Nee; I Chumakov; D Pollen; A Brookes; P Sanseau; R J Polinsky; W Wasco; H A Da Silva; J L Haines; M A Perkicak-Vance; R E Tanzi; A D Roses; P E Fraser; J M Rommens; P H St George-Hyslop
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.